Tickers: XTSX:EYC, PINX:EYCCF
Tags: Heathcare
Oakville, ON / TheNewswire / June 19 2018 - Eyecarrot Innovations Corp ("Eyecarrot" or the "Company") (TSX-V: EYC | OTCQB: EYCCF) is pleased to announce its participation at the 121ST American Optometric Association ("AOA") Meeting in Denver Colorado from June 20-24th. Eyecarrot will be showcasing the recently released Binovi Touch Saccadic Fixator in the Sports and Performance Vision Forum and will be exhibiting the Binovi Platform in the AOA Exhibit Hall.
"We are excited to be attending our first official AOA meeting since the development of the Binovi Platform. Our team has been working tirelessly to introduce and sign on practices across the USA, getting invaluable market data feedback, and working to supply the demand presented for the Binovi Touch hardware offering. The AOA meeting will be an opportunity to garner further insights from the thousands of Optometrists ("O.D.) attending the conference in Denver, and more importantly, bringing greater visibility to our World Class Binovi Platform". Commented CEO Adam Cegielski.
About the American Optometric Association
The American Optometric Association is the leading authority on quality care and an advocate for our nation's health, representing more than 44,000 doctors of optometry (O.D.), optometric professionals and optometry students. Doctors of optometry take a leading role in patient care with respect to eye and vision care, as well as general health and well-being. As primary health care providers, doctors of optometry have extensive, ongoing training to examine, diagnose, treat and manage ocular disorders, diseases and injuries and systemic diseases that manifest in the eye. Doctors of optometry provide more than two-thirds of primary eye care in the U.S.
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
President | CEO
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2018 TheNewswire - All rights reserved.
